No CrossRef data available.
Published online by Cambridge University Press: 23 November 2017
The benefits of adequate intakes of very long chain (VLC, carbon chain length ≥20) n-3 PUFA, in particular eicosapentaenoic acid (EPA, C20:5) and docosahexaenoic acid (DHA, C22:6) are well documented and crucially include a reduced risk of coronary heart disease. Although fish oils are a rich source of these fatty acids consumption of oily fish is low and it is now clear that in vivo synthesis of EPA and DHA from dietary α-linolenic acid is very limited, especially in men. This work assessed what the current dietary sources and intakes of EPA and DHA are, and how intake may be increased by enriching their concentration in foods of animal origin.